Sharp John P 4
4 · PhaseBio Pharmaceuticals Inc · Filed May 24, 2022
Insider Transaction Report
Form 4
Sharp John P
CFO and Secretary
Transactions
- Award
Common Stock
2022-05-20$0.68/sh+6,026$4,106→ 65,767 total
Footnotes (2)
- [F1]Shares were acquired under the Issuer's Employee Stock Purchase Plan ("ESPP") in a transaction that is exempt under both Rule 16b-3(c) and Rule 16b-3(d).
- [F2]In accordance with the ESPP provisions, these shares were purchased based on 85% of the closing price of the Issuer's common stock on May 20, 2022.